Janney Montgomery Scott LLC Biogen Inc. Transaction History

Janney Montgomery Scott LLC

$32.8 Billion
Q2 2024

A detailed history of Janney Montgomery Scott LLC transactions in Biogen Inc. stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 14,926 shares of BIIB stock, worth $2.98 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

14,926

Previous 15,970 6.54%

Holding current value

$2.98 Million

Previous $3.44 Million 0.46%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$190.52 - $236.72 $198,902 - $247,135	-1,044 Reduced 6.54%	14,926 $3.46 Million
Q1 2024 May 01, 2024	SELL	$212.02 - $267.71 $202,267 - $255,395	-954 Reduced 5.64%	15,970 $3.44 Million
Q4 2023 Feb 07, 2024	SELL	$222.59 - $267.94 $300,051 - $361,183	-1,348 Reduced 7.38%	16,924 $4.38 Million
Q3 2023 Nov 08, 2023	SELL	$253.3 - $285.89 $3.11 Million - $3.51 Million	-12,277 Reduced 40.19%	18,272 $4.7 Million
Q2 2023 Jul 26, 2023	BUY	$275.25 - $318.06 $3.27 Million - $3.78 Million	11,871 Added 63.56%	30,549 $8.7 Million
Q1 2023 Apr 28, 2023	SELL	$256.56 - $292.34 $30,787 - $35,080	-120 Reduced 0.64%	18,678 $5.19 Million
Q4 2022 Feb 01, 2023	SELL	$252.44 - $306.72 $1.36 Million - $1.65 Million	-5,392 Reduced 22.29%	18,798 $5.21 Million
Q3 2022 Oct 25, 2022	SELL	$194.69 - $268.46 $539,291 - $743,634	-2,770 Reduced 10.27%	24,190 $6.46 Million
Q2 2022 Aug 03, 2022	SELL	$187.54 - $223.02 $993,586 - $1.18 Million	-5,298 Reduced 16.42%	26,960 $5.48 Million
Q1 2022 May 04, 2022	BUY	$193.77 - $244.14 $913,625 - $1.15 Million	4,715 Added 17.12%	32,258 $6.79 Million
Q4 2021 Jan 27, 2022	SELL	$223.92 - $287.77 $504,043 - $647,770	-2,251 Reduced 7.56%	27,543 $6.61 Million
Q3 2021 Oct 29, 2021	BUY	$282.99 - $369.05 $28,581 - $37,274	101 Added 0.34%	29,794 $8.43 Million
Q2 2021 Jul 26, 2021	SELL	$259.0 - $414.71 $727,272 - $1.16 Million	-2,808 Reduced 8.64%	29,693 $10.3 Million
Q1 2021 Apr 27, 2021	BUY	$242.95 - $284.63 $214,767 - $251,612	884 Added 2.8%	32,501 $9.09 Million
Q4 2020 Jan 25, 2021	BUY	$236.26 - $355.63 $219,013 - $329,669	927 Added 3.02%	31,617 $7.74 Million
Q3 2020 Nov 06, 2020	SELL	$264.77 - $305.71 $239,087 - $276,056	-903 Reduced 2.86%	30,690 $8.71 Million
Q2 2020 Jul 23, 2020	SELL	$258.66 - $342.55 $226,327 - $299,731	-875 Reduced 2.69%	31,593 $8.45 Million
Q1 2020 Apr 30, 2020	SELL	$268.85 - $341.04 $303,262 - $384,693	-1,128 Reduced 3.36%	32,468 $10.3 Million
Q4 2019 Jan 21, 2020	SELL	$220.06 - $304.07 $670,082 - $925,893	-3,045 Reduced 8.31%	33,596 $9.97 Million
Q3 2019 Oct 29, 2019	SELL	$217.44 - $243.88 $112,851 - $126,573	-519 Reduced 1.4%	36,641 $8.53 Million
Q2 2019 Jul 29, 2019	SELL	$219.29 - $241.72 $2.32 Million - $2.56 Million	-10,578 Reduced 22.16%	37,160 $8.69 Million
Q1 2019 Apr 30, 2019	SELL	$216.71 - $338.96 $251,817 - $393,871	-1,162 Reduced 2.38%	47,738 $11.3 Million
Q4 2018 Feb 01, 2019	SELL	$278.5 - $352.75 $479,577 - $607,435	-1,722 Reduced 3.4%	48,900 $14.7 Million
Q3 2018 Nov 05, 2018	BUY	$293.51 - $383.83 $1.59 Million - $2.08 Million	5,431 Added 12.02%	50,622 $17.9 Million
Q2 2018 Jul 24, 2018	BUY	$257.52 - $306.91 $2.12 Million - $2.53 Million	8,229 Added 22.26%	45,191 $13.1 Million
Q1 2018 Apr 19, 2018	BUY	$260.13 - $367.91 $126,683 - $179,172	487 Added 1.34%	36,962 $10.1 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $223,039 - $249,820	725 Added 2.03%	36,475 $11.6 Million
Q3 2017 Nov 15, 2017	BUY	$281.15 - $329.69 $10.1 Million - $11.8 Million	35,750	35,750 $11.2 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Account

Janney Montgomery Scott LLC Biogen Inc. Transaction History